Drug Development

Articles

In combination with etoposide and either carboplatin or cisplatin, Imfinzi has been approved in the first-line setting of ES-SCLC by China’s National Medical Products Administration.

AstraZeneca’s Extensive-Stage Small Cell Lung Cancer Treatment Approved in China

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Modeling the manufacturing process benefits both development and operations. 

GSK Pilots Digital Twin for Vaccine Manufacturing 

MTBVAC has the potential to be used as an alternative to BCG vaccination in infants and for prevention of TB disease in adolescents and adults.

Zendal and IAVI to Advance Tuberculosis Vaccine Candidate into Efficacy Trials

ImmunityBio will proceed with a Phase I/II/III trial in South Africa of their dual-antigen T-cell vaccine as a boost in participants who were previously vaccinated against COVID-19.

SAHPRA Authorizes ImmunityBio to Proceed with Trial of T-Cell Vaccine as Booster Against COVID-19

The US federal government awarded new funding to the National Institute for Innovation in Manufacturing Biopharmaceuticals, including funding under the American Rescue Plan that will be used to advance vaccine manufacturing. 

NIIMBL Receives Federal Funding for Biopharmaceutical Manufacturing Projects

The new lab near Continuus Pharmaceutical’s current facilities in Massachusetts will expand the company’s process development capabilities to high-potency drugs.

Continuus Pharmaceuticals Opens Process Development Lab

UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.

SPI Pharma Introduces Platform for Orally Disintegrating Tablets

Univercells Technologies and VectorBuilder to produce custom viral vectors for cell and gene therapies as well as vaccine applications.

Custom Viral Vector Manufacturing Protocols to be Produced by Univercells Technologies and VectorBuilder

Tezepelumab, being developed by AstraZeneca in collaboration with Amgen, reduced asthma exacerbations in Phase II and III clinical trials. 

FDA Grants Priority Review for AstraZeneca Asthma Biologic

An additional batch of the Janssen COVID-19 vaccine has been authorized by FDA under the Emergency Use Authorization.

Formulation and Drug Delivery